Nitrosamine Impurities in Medicinal Products
Konstantina Konstantinopoulou2020-12-17T15:29:32+00:00Nitrosamine Impurities in Medicinal Products Back to Kinapse blog In 2018, the unexpected discovery of nitrosamine (probable human carcinogen) impurities in several angiotensin receptor blockers (ARBs) triggered a series of regulatory actions [...]